T2 Biosystem Slashes FY23 Sepsis Product Revenue Forecast

T2 Biosystems, Inc. (NASDAQ: TTOO) announced preliminary results 

T2 Biosystems, Inc. (NASDAQ:TTOO) announced preliminary results for the second quarter of 2023.

The company is expected to achieve second-quarter total revenue of $2 million. It includes sepsis test panel revenue of $1.3 million, representing an increase of 7% compared to the prior year.

T2 ended the second quarter with a $0.4 million sepsis test backorder.

In the second quarter, T2 secured a multi-year contract with a European distributor for 7 T2Dx Instruments and sepsis test panels for Poland.

T2  implemented a restructuring program in May 2023, including a workforce reduction of nearly 30%.

The company expects to exit the quarter with cash and equivalents worth $16.1 million.

The company now expects full-year 2023 total sepsis and related product revenue of $9.5 million-$10.5 million (down from the prior view of $11.0 million-$13.0 million), representing growth of 13% to 25%, compared to $8.4 million in 2022.

The company plans to announce the complete second quarter 2023 financial results in August.

Price Action: TTOO shares are trading lower by 12% to $0.1318 on the last check Wednesday.

Total
0
Shares
Related Posts
Read More

Heritage Cannabis’ Stock Plunges On Announcing Creditor Protection, Looks To Pursue Restructuring And Sales Process

Heritage Cannabis Holdings Corp. announced on Tuesday that alongside its subsidiaries it sought and obtained an order for creditor protection from the Ontario Superior Court of Justice under the Companies Creditors Arrangement Act. "The difficult but necessary decision to commence CCAA proceedings was made after careful consideration of the Company's financial position while evaluating all available alternatives and engaging in significant consultation with legal and financial advisors," the company said in a press release. The Toronto-based cannabis producer also said that BJK Holdings Ltd., its senior secured lender, made a demand to the company for payment in full of certain indebtedness owing by the Heritage Group to the lender totaling $8,421,088.87. Heritage has entered into binding agreements to sell its real estate properties in Ontario and British Columbia to BJK Developments Ltd. for a net purchase price of $9,714,475 and lease the Ontario and BC Property back from the purchaser in October. The company said at the time the purchase would be used to set off the amount owing by the company to its lender, BJK Holdings Ltd., a related entity of the purchaser, reducing the company's remaining term debt by roughly 64% to $5,256,379. The remaining term financing, as amended within a third amending agreement, has been extended through to Jan. 31, 2025. Additionally, the company said it retains its revolving line of credit of up to $5 million with BJK, which has also been extended until the same date.

CANN